Mylan Investor Relations

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 7,500 marketed products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.


Mylan (MYL) NASDAQ | Oct 17, 2017, 4:00 ET

+ 0.36
Day High: 38.66
Day Low: 38.01
Volume: 4,239,818
52-Week High: 45.87
52-Week Low: 29.39


Third Quarter 2017 Financial Results

November 06, 2017

Second Quarter 2017 Financial Results

August 09, 2017

Goldman Sachs 38th Annual Global Healthcare Conference
Location: Rancho Palos Verdes, CA

June 14, 2017


In order to set new standards in healthcare, we have leaders dedicated to helping people gain access to affordable medicine on a global scale. Learn about the passionate people who carry out Mylan’s day-to-day business and bring quality to our facilities.

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.